Valye reports for unlimited access

The Trust was established as a Delaware statutory trust in January 2023 to invest exclusively in EU Carbon Emission Allowances (EUAs) for stationary installations under the European Union Emissions Trading System (EU ETS). It issues Shares representing fractional interests in the Trust's net assets, which consist solely of EUAs and cash. Shares are created and redeemed in large blocks called Baskets by Authorized Participants at NAV. The Trust's NAV is calculated daily based on EUA market prices and cash holdings. The Trust does not engage in discretionary trading or hedging but holds EUAs to track their price performance less expenses. The Sponsor, COtwo Advisors LLC, manages the Trust and pays routine expenses, while State Street Bank and Trust Company serves as Transfer Agent, Administrator, and Cash Custodian. Liquidity providers such as Vertis and Redshaw facilitate the purchase and sale of EUAs to support creation and redemption of Shares. The Trust's Shares trade on NYSE Arca under the symbol CTWO and may trade at premiums or discounts to NAV depending on market conditions and EUA liquidity. The Trust is not registered as an investment company or commodity pool and operates under a defined regulatory framework [S1][S2].

Arrive AI Inc. is focused on building the essential infrastructure for the Autonomous Last Mile (ALM) era, where last-mile logistics are dominated by drones and robotic delivery systems. Its flagship product, the Arrive Points™ network, consists of smart lockers and mini-cross-docks that serve as secure, asynchronous exchange points connecting various delivery stakeholders. The company’s integrated ALM Platform combines this physical network with an ALM Marketplace for dynamic scheduling and transactional optimization, and AI Services for data-driven insights and automation. Arrive AI’s multi-generational hardware supports universal compatibility with major delivery systems, robust security, and features such as temperature assistance. The company has secured pilot programs with significant customers and aims to deploy 100,000 Arrive Points over five years, targeting a balanced revenue model between Network-as-a-Service and Marketplace & AI Services.

Webstar Technology Group Inc. was originally established to operate licensed software solutions but has transitioned to an early-stage specialty real estate development company focused on multi-tenant buildings with green/energy efficient upgrades and entertainment and resort real estate projects. The company formed a subsidiary, Forge Atlanta Asset Management LLC, to develop a 10-acre mixed-use real estate project in Downtown Atlanta. It has acquired commercial property for $34.5 million as part of this strategy and is pursuing financing through taxable revenue bonds and promissory notes. The company has minimal operating capital, no revenue, and reported a net loss for the latest fiscal year. It operates with a small team and relies on external consultants for public company filings. The business model involves capital-intensive real estate development with significant financial and operational risks [S1].

OMNIQ Corp. is a technology company specializing in AI-driven machine vision image processing solutions. Incorporated in 1973 and transitioning focus since 2014, OMNIQ has grown through acquisitions to serve complex environments such as airports, campuses, municipalities, and healthcare facilities. Its technology platform integrates proprietary computer vision software, AI models, and edge computing to provide real-time analytics for vehicle and pedestrian monitoring, automated enforcement, and operational oversight. The company targets public safety, hospitality, and supply chain management markets, offering hardware, software, and services designed to improve operational visibility and efficiency. OMNIQ's sales strategy includes direct sales teams supported by technical experts, with a focus on national accounts and the Israeli market. The company operates in a competitive landscape but differentiates through comprehensive solutions and data privacy infrastructure [S1].

Superstar Platforms Inc. is a Nevada-based technology-focused holding company that seeks to acquire, develop, and manage a diversified portfolio of subsidiaries. Its primary current operations include PawnTrust, a technology-enabled marketplace platform designed to serve approximately 11,000 pawn shops in the U.S., and capital deployment activities through promissory notes. PawnTrust aims to digitize pawn shop inventory and facilitate transactions via a mobile app, generating revenue through transaction fees, though it remains in development and has not yet generated revenue. The company’s capital deployment involves structured lending arrangements generating interest income. Superstar Platforms intends to grow through strategic acquisitions and organic development, focusing on technology-enabled marketplaces and financial services solutions. The company faces liquidity challenges, with a working capital deficit and accumulated losses, and relies on executive officers and third-party service providers for operations.

SurgePays, Inc. operates as a wireless and point of sale technology company targeting underserved and value-conscious consumers. Its business model integrates mobile connectivity, financial technology services, and transaction processing through a platform combining wireless services with point of sale software and a nationwide retail distribution network. The company distributes its products and services primarily through a network of over 9,000 independently owned convenience stores and similar retail locations, complemented by digital acquisition channels such as ProgramBenefits.com. SurgePays offers subsidized wireless services via government-supported programs like Lifeline, prepaid wireless services under brands including LinkUp Mobile, and wholesale enablement services as a mobile virtual network enabler. Additionally, it provides point of sale transaction processing and in-store digital advertising through its Managed Marketing Services platform. The company emphasizes capital efficiency and growth through subscriber acquisition, cross-selling, and operational optimization. SurgePays operates in a competitive market with national carriers, MVNOs, fintech firms, and prepaid distributors, differentiating itself by combining telecommunications and transaction services on a single platform focused on underserved and rural communities [S1].

Abpro Holdings, Inc. is a biotechnology company focused on developing novel antibody therapeutics using proprietary DiversImmune® discovery and MultiMab™ engineering platforms. The company targets severe diseases in immuno-oncology, ophthalmology, and infectious disease. It completed a reverse recapitalization merger in November 2024, resulting in its common stock initially trading on Nasdaq and subsequently delisted to OTC Pink due to non-compliance. The company’s lead product candidates are ABP-102, a next-generation T-cell engager targeting HER2 and CD3 for HER2-positive solid tumors, and ABP-201, a ligand trap targeting VEGF and ANG-2 for vascular diseases of the eye including wet age-related macular degeneration. ABP-102 has received FDA IND clearance enabling Phase 1 clinical trials led by partner Celltrion. ABP-201 is planned for Phase 1 clinical evaluation. The company has strategic partnerships with Celltrion, Abpro Bio, and NJCTTQ for development and commercialization. Financially, the company reported limited revenue, net losses, and liquidity constraints as of December 31, 2025, with substantial doubt about its ability to continue as a going concern without additional funding.

RemSleep Holdings Inc. is a medical device company focused on developing and commercializing sleep therapy products, primarily the DeltaWave(TM) CPAP mask and nasal pillow system. The company operates as a smaller reporting entity and trades on the OTCQB market. It has recently completed FDA 510(k) clearance processes and launched its products commercially. Leadership transitioned in early 2026 following the passing of the founder, with Jeffrey Marshall appointed as CEO. The company has engaged in distributor agreements and outlined commercial strategies targeting expanded FDA applications and institutional market entry.

TruGolf Holdings, Inc. is a Nevada-based golf technology company with a history tracing back to Access Software and the Links video game franchise. The company focuses on indoor golf simulation hardware, software, and related services. Its product portfolio includes proprietary launch monitors such as APOGEE and LaunchBox, a range of golf simulator systems from portable to premium custom installations, and software platforms including E6 CONNECT (legacy) and E6 GOLF (next-generation). TruGolf serves residential, commercial, instructional, entertainment, and portable-use markets. The company operates through three main channels: hardware design and sales bundled with software, software licensing, and development of commercial and franchise indoor golf solutions. Market trends show growth in both traditional and off-course golf participation, with increasing demand for simulator-based play and technology-enabled golf venues. TruGolf is expanding its franchise operations and developing digital competition frameworks like the Virtual Golf Association. The company maintains a network of resellers and partners domestically and internationally. It faces competition from integrated hardware/software providers and software-only platforms but leverages its long operating history and integrated platform as competitive strengths.

Premier Air Charter Holdings Inc. operates in the private air charter sector, providing personalized air travel services. The company has been actively expanding its fleet and capabilities through acquisitions of high-performance aircraft such as the Citation X and Challenger 604. It serves markets including Hawaii and Mexico, where it has reported growth. The company engages in capital restructuring activities, including debt conversions to preferred stock, to manage its financial position.

Global Gas Corporation operates as a pure-play hydrogen and carbon recovery project developer and industrial gas supplier. Founded in 2023, the company is building a project development pipeline focused on supplying low-carbon hydrogen, recovered CO2, oxygen, and related industrial gases primarily in North America, Western Europe, and Great Britain. The business model includes sourcing local feedstocks, often renewable waste, and deploying modular generation and recovery equipment close to end customers to reduce distribution costs. Revenue generation is planned through sales of systems and equipment, including electrolyzers and carbon recovery plants, as well as technical and project management services. The company targets customers such as heavy duty fleet operators and industrial gas users. Global Gas faces competition from equipment manufacturers and established industrial gas suppliers. The company has a limited operating history, no significant revenue until recently, and is dependent on raising additional funds and managing regulatory and operational risks [S1,S2].

Texas Ventures Acquisition III Corp is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in July 2024. It has no material operations and was formed to complete a business combination with one or more target companies in any industry. The company completed its initial public offering in April 2025, raising gross proceeds of $225 million by selling units consisting of Class A ordinary shares and warrants. The proceeds are held in a trust account invested in U.S. government securities until a business combination is completed or funds are returned to shareholders. The company has a management team with experience in financial services and transaction execution, which it leverages to identify and evaluate potential acquisition targets. As of the end of 2025, the company had not commenced operations and had no operating revenues. It generates non-operating income from interest on trust account investments. The company is currently engaged in discussions regarding a potential business combination but has not finalized any agreements.

QVC INC is a retailer that markets a broad range of merchandise primarily through television shopping programs and digital platforms including streaming and social media. The company operates internationally, with sales denominated in local currencies outside the U.S. Its business model relies on sourcing and selling consumer products, with exposure to supply chain, tariff, and currency risks. The company reported revenues of $8.29 billion and a net loss of $2.17 billion for fiscal 2025. Liquidity is constrained, with a current ratio below 1.0 and significant near-term debt maturities. The company is actively evaluating refinancing options for its Credit Facility due in October 2026. Credit rating downgrades in 2025 reflect concerns about financial stability and access to capital markets [S1][S2].

BRB Foods Inc. is a Wyoming-incorporated holding company operating in Brazil through its subsidiaries BR Brands S.A. and Boni Logistica Ltda. BR Brands focuses on the development, manufacturing coordination, and commercialization of dry food products, primarily pasta, distributed to wholesalers, supermarkets, and retail chains. Boni Logistica supports logistics coordination and distribution management, utilizing a network of 14 third-party independent distribution centers across Brazil. The company operates a B2B2C business model, selling products to wholesalers and retailers who then sell to end consumers. Historically, BRB Foods commercialized products under intellectual property license agreements with Unilever covering brands such as Arisco, Knorr, Maizena, and Mãe Terra. As of April 2026, three of these license agreements have expired, covering 46 of 61 planned new products, and the remaining Knorr license is set to expire on June 30, 2026. The company suspended revenue-generating activities in Q2 2024 to focus on operational readiness and product portfolio development and has not generated revenue since then. The company's ability to resume commercial activities depends on product readiness, licensing status, market conditions, and capital availability. BRB Foods employs approximately 30 employees in Brazil and has implemented enterprise systems including SAP Business One, WMS, and TMS to support operations.

Ameritek Ventures, Inc. was originally organized in 2010 and transitioned from a software company to a diversified technology holding company by 2025. The company sold its software subsidiaries in late 2024 and acquired Galaxy Batteries, Inc. in 2025, shifting its focus to solid-state batteries, adaptive and robotic manufacturing, aerospace services, and luxury corporate housing. It operates multiple subsidiaries including AeroPass, Inc. and Chicago Real Estate Partners, LLC, which manages furnished luxury condominiums for corporate clients. The company continues to operate DittoMask, Inc. until inventory is sold and plans to divest CordTell, Inc. and WebBeeO, Inc. to an affiliate. Ameritek has also merged with other companies to acquire new products and patents, including augmented reality and robotic technologies.

Nauticus Robotics, Inc. is a technology-driven company specializing in fully electric autonomous subsea robotic solutions. Its product portfolio includes the Aquanaut autonomous underwater vehicle capable of deep-sea operations, the Nauticus ToolKITT software suite enabling autonomous navigation and task execution, and the Olympic Arm electric manipulator designed for complex subsea interventions. The company serves a broad addressable market spanning offshore energy, defense, offshore renewables, subsea mining, and oceanographic research, with a primary focus on oil and gas and defense sectors. Nauticus operates as a single segment with substantial U.S. operations and is expanding internationally. The company faces competition from established ROV manufacturers, software providers, and defense contractors. Nauticus funds its operations through equity offerings, debt facilities, and strategic investments while managing liquidity constraints.

Nature's Miracle Holding Inc. is an agriculture technology company focused on providing Controlled Environment Agriculture (CEA) hardware products to growers in North America. Through its subsidiaries Visiontech Group Inc. and Hydroman, Inc., it supplies grow lights, grow media products, and dehumidifiers for indoor and greenhouse cultivation. The company also facilitates energy rebate solutions linked to LED lighting qualifying for utility rebates. It has developed automated container-sized vertical farms that can match the output of multiple acres of farmland. The company designs mid-to high-end LED and dehumidifier products, sources manufacturing overseas, and distributes from a warehouse in California. Grow media is imported under private label from Europe, India, and other regions. The company primarily serves wholesale distributors and retailers in the U.S. and Canada. In 2025, it generated approximately $1.74 million in revenue but incurred a gross loss and net loss, reflecting ongoing challenges in achieving profitability. The company also owns commercial real estate in Toledo, Ohio, which began generating rental income in late 2025. The business operates in a competitive and fragmented industry with a focus on product quality, brand awareness, and innovation. It faces risks related to supplier concentration, supply chain disruptions, and liquidity constraints [S1].

QVC Group, Inc. operates primarily in the video and online commerce industries through its subsidiaries QVC, Inc., Cornerstone Brands, Inc., and others. Its largest segments include QxH (QVC U.S. and HSN), QVC International, and CBI. QVC is a live social shopping company that markets and sells a broad assortment of consumer products across multiple platforms including television, websites, mobile applications, and social media. The company emphasizes curated, exclusive, and branded merchandise, often endorsed by celebrities, targeting a core demographic of women over 50. QVC Group's operations span North America, Europe, and Asia, with significant distribution infrastructure and a large customer base. The company has recently undergone a name change, a reverse stock split, and is currently in Chapter 11 bankruptcy proceedings, impacting its capital structure and market listing. QVC Group is implementing strategic initiatives such as the WIN strategy to enhance customer engagement and operational efficiency.

My Size, Inc. operates a comprehensive fashion technology platform designed to solve key challenges for fashion brands and retailers: size and fit accuracy, excess inventory, sustainability through circular economy solutions, and international market distribution. The platform integrates four business units: Naiz Fit (AI-driven size and fit SaaS platform), ShoeSize.Me (footwear sizing AI), Orgad (Amazon third-party seller managing over 5,000 SKUs), Percentil (European recommerce platform), and Ten Peacks (brand distribution in Israel). The company’s strategy emphasizes an integrated approach allowing brands to address multiple operational challenges with a single partner, leveraging shared data and commercial synergies. The company pursues growth through expanding U.S. commercial agreements, cross-selling across units, scaling recommerce services driven by EU regulations, technology commercialization, AI platform enhancements, proprietary data asset development, and acquisitions. The company’s financial snapshot as of December 31, 2025, shows modest revenue with net income and liquidity ratios indicating operational capacity but also historical losses and accumulated deficit. The company’s headquarters in Israel expose it to geopolitical risks. Recent acquisitions and formation of subsidiaries support platform expansion and market reach [S1][N1].

Q/C Technologies, Inc. is a technology company that has shifted its business strategy from pharmaceutical development to laser-based computing for blockchain infrastructure, decentralized physical infrastructure networks, and AI-driven high-performance computing. The company leverages an exclusive global license with LightSolver Ltd. to develop and commercialize laser processing units (LPUs), including the qc-LPU100, which aims to provide high computational speed and energy efficiency. The company is currently in early-stage prototype development and benchmarking, with commercialization dependent on successful validation and customer adoption. Legacy pharmaceutical programs, including Isomyosamine and Supera-CBD, remain as reportable segments but are under strategic review for potential divestiture. The company holds a substantial patent portfolio covering both its laser computing and pharmaceutical technologies. Financially, the company reported a net loss of $11.6 million for 2025 and maintains a strong liquidity position with a current ratio of 3.0 as of year-end 2025. The company faces significant competition from established semiconductor and biotech firms, regulatory complexities across multiple jurisdictions, and risks related to capital requirements and intellectual property protection.

ENvue Medical Inc, formerly NanoVibronix, is a Delaware-based medical device company specializing in enteral feeding technologies. Its core product, the ENvue System, is an electromagnetic navigation platform designed to improve the safety and efficiency of feeding tube placement in hospitalized patients. The system is FDA 510(k)-cleared for use in adults and is marketed primarily in the U.S. acute care hospital sector. ENvue's business model combines sales of the navigation system with recurring sales of proprietary disposable feeding tubes and accessories. The company is in the growth phase of commercialization, with multiple hospital engagements and efforts to expand market penetration through direct sales and distribution partnerships. ENvue also develops complementary products and is advancing a robotic platform to automate aspects of feeding tube placement. The company faces competition from other navigation and visualization technologies and operates under regulatory oversight with ongoing clinical and product development activities.

Cytosorbents Corp develops and markets medical devices based on polymer technology, including the CytoSorb cytokine adsorber and other devices such as ECOS-300CY, PuriFi pump, VetResQ, and DrugSorb-ATR. The company’s products target critical care and other medical applications. Regulatory approval and market acceptance are key factors for commercial success. The company is actively engaged in regulatory processes with the FDA and Health Canada for DrugSorb-ATR, including appeals and planned resubmissions. Financially, the company reported a net loss in 2025 and maintains liquidity with a current ratio above 2. The company’s common stock is listed on Nasdaq but has faced minimum bid price compliance issues. The board and executive team have extensive experience in healthcare and medical device sectors.

CirTran Corporation is a contract manufacturer and marketer of consumer products, including tobacco, medical devices, beverages, and licensed adult lifestyle products under the HUSTLER® brand. The company operates through subsidiaries and holds exclusive manufacturing and distribution rights under agreements with licensees such as GloBrands, LLC. CirTran provides end-to-end product development and manufacturing services, leveraging offshore manufacturing partnerships to manage costs and scale production. The company also pursues contract marketing relationships in various consumer product categories and licenses recognized brand names for product commercialization.

Vivakor, Inc. is a Nevada-based integrated midstream energy company providing crude oil transportation, terminaling, marketing, and remediation services primarily in the Permian, Eagle Ford, and Anadarko Basins. The company operates trucking fleets, pipelines including the Omega Gathering Pipeline, and terminaling facilities in Texas and Louisiana. Its marketing and trading segment manages commodity purchases and sales, leveraging its transportation and storage network. The remediation segment is developing a processing center in Texas to recover hydrocarbons from oilfield waste. Vivakor's business model integrates multiple midstream services to capture margin across the crude oil value chain, supported by long-term contracts and strategic acquisitions. The company faces financial challenges including net losses and liquidity constraints but pursues growth through asset optimization and expansion of remediation services [S1].

Mitesco, Inc. was formed in 2012 and has transitioned from operating medical clinics to focusing on data center and cloud computing services. It operates two main subsidiaries: Centcore, providing data center and managed services via co-location agreements and exploring smaller data center formats; and Vero Technology Ventures, developing AI-based cloud applications such as Robo Agent for sales processes. The company has no full-time employees and relies on consultants and directors. It faces competition from established IT service providers and cloud vendors. Mitesco has a history of losses and limited liquidity, with recent efforts focused on financial restructuring and strategic shifts toward technology services.

Drugs Made In America Acquisition Corp. is a Cayman Islands exempted blank check company formed to effect a business combination with one or more target companies. It has no operations or revenue and is classified as a shell company. The company completed its IPO in January 2025, issuing units consisting of ordinary shares and rights, raising gross proceeds of $200 million plus over-allotment and private placement proceeds. The proceeds are held in a trust account invested in U.S. government securities. The company’s strategy is to identify and acquire businesses in AI, pharmaceutical, or other sectors requiring rapid innovation, leveraging its management team's experience and networks. It has established investment criteria focusing on proven industry leaders with defensible business models and growth potential. The company has begun preliminary due diligence on a potential business combination with Power Analytics Global Corp., an enterprise technology platform focused on AI and cybersecurity, but no definitive agreement has been signed. The company has experienced recent management changes and has arranged interim financing to cover expenses related to a business combination. It depends on third-party digital technologies and has limited cybersecurity resources [S1][S2].

Atlantic International Corp. is a company engaged in workforce solutions primarily through its subsidiary Lyneer Staffing Solutions. Lyneer provides staffing services and has integrated AI technologies into its platforms to enhance workforce intelligence and operational efficiency. The company has expanded its business through acquisitions such as Staffing 360 Solutions and Circle8 Group, and has secured contracts with major North American companies. Atlantic International was added to the Russell 3000® Index in mid-2025 and has made key executive appointments to support its operations. Financial disclosures indicate significant net losses and liquidity challenges, with ongoing efforts to restructure substantial joint debt obligations shared with its principal stockholder IDC. The company has also completed a preferred stock offering to support working capital needs.

United Health Products, Inc. specializes in developing, manufacturing, and marketing CelluSTAT, a patented hemostatic gauze derived from cotton. CelluSTAT is FDA-cleared for superficial bleeding and is designed to absorb wound exudate and control bleeding without chemical additives or animal-derived components. The company is actively seeking FDA Premarket Approval for Class III surgical use in the U.S. and CE Mark approval in Europe. The product converts to a translucent gel upon contact with blood, facilitating monitoring of coagulation while maintaining tissue compatibility. Manufacturing is outsourced to FDA-certified suppliers with packaging and sterilization in the U.S. The company holds patents protecting its technology through 2029 and has multiple registered trademarks. United Health Products targets hospitals, surgery centers, EMS, military medical providers, hemodialysis centers, nursing homes, dental offices, and veterinary hospitals as potential customers. The company faces competition from large established wound care companies with greater resources. It has no current revenue and operates at a loss, relying on financing and strategic partnerships to advance its regulatory and commercial objectives.

Mannatech Inc is a publicly traded company incorporated in Texas, United States, with its principal executive offices located in Flower Mound, Texas. The company is listed on the Nasdaq Stock Market under the ticker symbol MTEX. Public disclosures provide limited detail on the company's specific industry classification or product offerings. Financial data from the fiscal year ended December 31, 2025, shows the company experienced a net loss and maintains modest liquidity. Governance structures include board oversight of cybersecurity risks. Recent news highlights include leadership changes, loan extensions with related parties, dividend payments, and quarterly earnings updates indicating variable financial performance.

Nocera, Inc. is a public company listed on Nasdaq under the ticker NCRA, headquartered in New Taipei City, Taiwan. Its business operations focus on two main segments: Fish Trading, conducted through its Taiwan subsidiary, primarily trading eels and planning to expand to other seafood; and E-Commerce, acting as an agent for third-party product sales via live-streaming platforms. The company also provides consulting services for recirculation aquaculture systems (RAS) but discontinued bulk production of RAS units in 2022. It sold its Catering segment interest at the end of 2025. Nocera has made equity investments in e-commerce companies in the U.S. and France. The company owns land in Alabama intended for RAS development but has suspended those plans. It faces regulatory compliance across multiple jurisdictions and operates with a small workforce. Financially, it reported $13.63 million in revenue and a net loss of $2.88 million for 2025, with strong liquidity ratios but ongoing concerns about its ability to continue as a going concern. The company received a Nasdaq deficiency letter in 2026 due to its stock price and is actively addressing compliance.

American Strategic Investment Co., formerly known as New York City REIT, Inc., is an externally managed company owning a portfolio of commercial real estate primarily in Manhattan, New York City. The portfolio consists mainly of office properties and related assets such as retail spaces and parking garages. As of December 31, 2025, the company owned five properties totaling approximately 0.7 million rentable square feet, excluding one property undergoing consensual foreclosure. The company changed its business strategy in late 2022, terminating its REIT election effective January 1, 2023, to broaden the types of assets it may own and operate. The company is managed by New York City Advisors, LLC, and operates as a single reportable segment focused on income-producing properties. The company has faced challenges including occupancy declines, mortgage covenant non-compliance, and liquidity constraints, with ongoing efforts to remediate internal control weaknesses.

LQR House Inc. is a Delaware corporation focused on the alcoholic beverage industry, operating primarily through its wholly owned subsidiaries. Its core business includes the CWSpirits.com e-commerce platform offering a wide range of spirits, wines, and champagnes in the U.S., marketing services targeting the alcohol sector, and the development and marketing of its in-house tequila brand, SWOL Tequila. The company emphasizes direct-to-consumer marketing via social media, influencer networks, and digital campaigns. It maintains strategic partnerships, including exclusive distribution agreements and a key relationship with Country Wine & Spirits, Inc. (CWS), which serves as its sole distributor. LQR House has expanded its footprint through minority investments in wineries and non-alcoholic beverage companies and has engaged in joint ventures for digital content creation, though these were terminated with full return of invested funds. The company has undergone corporate restructuring, including stock splits and increases in authorized shares, and has raised capital through equity offerings. It faces operational risks related to distribution reliance, regulatory compliance, cybersecurity, and capital needs.

CDT Equity Inc. is a Delaware-based pharmaceutical development company that leverages artificial intelligence, solid-form chemistry, and asset repositioning to develop novel therapeutic assets. The company focuses on clinical-stage compounds with strong Phase I safety data, particularly those deprioritized by larger pharmaceutical companies. Its proprietary technologies improve drug properties and extend patent life by up to 20 years. CDT's pipeline includes candidates for autoimmune disorders, idiopathic male infertility, oncology, dermatology, rare diseases, and animal health. The company operates a lean, asset-agnostic model, avoiding the costs of early and late-stage clinical trials by focusing on high-leverage development strategies. Key strategic partnerships include Sarborg Limited, which provides AI-powered signature analysis and decision-support tools, and Manoira Corporation, which collaborates on animal health applications. CDT holds exclusive licenses from AstraZeneca for compounds AZD1656, AZD5658, and AZD5904. The company plans to monetize its assets through licensing and royalty agreements following successful pre-clinical trials. Manufacturing and testing are outsourced to third parties. Financially, CDT reported a net loss of $39.2 million for 2025, with limited liquidity and substantial doubt about its ability to continue as a going concern without additional funding [S1].

Solidion Technology Inc. originated as Nubia Brand International Corp., a special purpose acquisition company formed in 2021, and completed its business combination with Honeycomb Battery Company in February 2024, after which it was renamed Solidion Technology, Inc.[S1][N1]. The company focuses on developing and commercializing advanced battery materials and energy storage solutions, including silicon-rich anode materials, solid-state battery technology, and fire-retardant electrolytes. Its innovations include silane-free and CVD-free silicon anode production methods, elastomer protection technology for silicon particles, biochar-derived anodes with lower carbon footprint, and FireShield™ electrolytes compatible with existing lithium-ion battery manufacturing. Solidion holds a substantial intellectual property portfolio with over 345 active patents globally, supporting its leadership in next-generation battery technologies. The company has strategic partnerships to advance SiOx anode production in the U.S. and leverages global toll manufacturing to scale battery cell production. Financially, as of December 31, 2025, Solidion reported minimal revenue, significant net losses, and liquidity constraints, with a current ratio of 0.04 and cash ratio of 0.01, raising concerns about its going concern status. The company also adopted a Bitcoin allocation policy for its treasury in late 2024.[S1]

Vivos Therapeutics, Inc. develops and markets proprietary oral appliances and therapeutic protocols collectively known as The Vivos Method, designed to non-surgically treat maxillofacial abnormalities associated with obstructive sleep apnea (OSA) and snoring. The company’s products include FDA-cleared devices such as the DNA, mRNA, mmRNA, Vida, and Versa appliances, which are used in combination with adjunctive therapies like myofunctional therapy and chiropractic treatments. Since 2024, Vivos has shifted its business model from primarily training independent dentists to a medical-provider focused approach, acquiring and managing sleep medical practices and establishing Dental and Medical Service Organizations (DSOs and MSOs) branded as Sleep and Airway Medicine Centers (SAMC). This model integrates diagnostics, treatment, and administrative services to expand patient access and revenue streams. The company’s acquisition of The Sleep Center of Nevada (SCN) in 2025 marked a key milestone in this pivot. Vivos also operates The Vivos Institute, a clinical education center for healthcare providers. The company faces operational constraints including limited physical space, provider recruitment, and insurance credentialing delays, but aims to expand through additional acquisitions and strategic alliances.

Allied Energy, Inc. is a Canadian investment holding company focused on technology-enabled businesses, primarily operating through its indirect subsidiary BILI, Inc. BILI offers an AI-powered social commerce platform that enables social media creators to monetize their content by connecting with brands. The platform includes BILI Base™, which allows creators to sell products directly, and BILI Boost™ and BILI Boost+™, which provide AI-enabled marketing campaign services with guaranteed audience engagement metrics. The company targets a broad market including enterprise and small-to-medium brands, commerce creators, and content creators, mainly in North America with some international clients. BILI has established exclusive partnerships with sports organizations to access athlete creators and operates with a lean workforce and asset-light model. The company faces competition from well-capitalized platforms and agencies but leverages AI integration and vertical specialization as differentiators.